Single Dose of Dexamethasone in Femur Fractures
|ClinicalTrials.gov Identifier: NCT01550146|
Recruitment Status : Unknown
Verified March 2012 by Szilard Szucs, Cork University Hospital.
Recruitment status was: Recruiting
First Posted : March 9, 2012
Last Update Posted : March 9, 2012
Fracture neck of femur is a common cause of hospital admission in the elderly and requires operative fixation.
Dexamethasone has the potential of inhibiting cortisol secretion. In addition, preoperative glucocorticoids improve analgesia and decrease opioid consumption with reduction in associated side effects in a variety of clinical settings.
The investigators hypothesis was that a single dose of preoperative dexamethasone enhance postoperative analgesia and attenuates the inflammatory response in patients undergoing operative fixation of fractured neck of femur, in a prospective, randomized, placebo controled trial.
|Condition or disease||Intervention/treatment||Phase|
|Fractured Neck of Femur||Drug: Dexamethasone acetate Drug: Placebo||Phase 4|
Having obtained ethical approval and written informed consent from each, 40 patients scheduled to undergo operative fixation of fractured neck of femur will be randomized using sealed envelopes to two groups.
Patients in the Dexamethasone group receive a single dose of 0.1 mg/kg dexamethasone iv. preoperative, patients in the Placebo group receive the same amount of Normal Saline. The anaesthetic technique is standardized, salive samples, blood samples are taken and pain scores are measured on a visual analog scale postoperatively at several timepoints.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||40 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|
|Official Title:||Effects of a Single Dose of Dexamethasone in Patients Undergoing Operative Fixation of Proximal Femur Fracture|
|Study Start Date :||July 2009|
|Primary Completion Date :||January 2012|
|Estimated Study Completion Date :||July 2012|
Experimental: Dexamethasone, 0.1 mg/kg
The patients in the Dexamethasone group get iv 0.1 mg/kg dexamethasone preoperative.
Drug: Dexamethasone acetate
iv. dexamethasone 0.1 mg/kg
Placebo Comparator: Placebo
In the Placebo group the patients get 0.1 ml/kg normal saline.
iv. Normal Saline 0.1 ml/kg
- Visual analogue pain scale at rest and on movement postoperatively [ Time Frame: Postoperative in recovery, 6, 12, 24, 48, 72 hourly ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01550146
|Cork University Hospital||Recruiting|
|Contact: Szilard Szucs, MD +353872730724 email@example.com|
|Contact: Gabriella Iohom, MD, PhD +353-21-4922135 firstname.lastname@example.org|
|Principal Investigator: Szilard Szucs, MD|